Carcinogenesis, Vol. 21, No. 4, 669-676,
April 2000
© 2000 Oxford University Press
Carcinogenesis |
CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure
1 Institute of Environmental Medicine, Karolinska Institutet, Stockholm,
2 National Institute for Working Life, Stockholm,
3 Department of Occupational and Environmental Medicine, University Hospital, Umeå,
4 Department of Occupational and Environmental Medicine, University Hospital, Lund,
5 National Institute for Working Life, Department of Chemistry, Umeå and
6 Department of Analytical Chemistry, Stockholm University, Stockholm, Sweden
Certain human biotransformation enzymes have been implicated in the formation and scavenging of the ultimate reactive metabolites, the diolepoxides, from polycyclic aromatic hydrocarbons (PAHs). In the present study, performed on aluminum smelter workers, we have analyzed airborne PAH, the pyrene metabolite 1-hydroxypyrene (1-OHP) in urine, and genotypes for biotransformation enzymes involved in PAH metabolism. The aim was to evaluate the correlation between external exposure and biomarkers of exposure and to investigate to what extent genetic polymorphism in metabolic enzymes can explain interindividual variation in urinary 1-OHP levels. DNA was prepared from blood samples from 98 potroom workers and 55 controls and altogether eight polymorphisms in the CYP1A1, mEH, GSTM1, GSTP1 and GSTT1 genes were analyzed. The 1-OHP excretion was found to correlate significantly (P 
0.005) to the exposure. The interindividual difference in excretion of 1-OHP was vast (>100-fold) and univariate and multivariate regression analyses were used to find the variables that could determine differences in excretion. The variation could, to some degree, be explained by differences in exposure to airborne particulate-associated PAHs, the use of personal respiratory protection devices, smoking habits and genetic polymorphisms in the cytochrome P450 1A1, GSTM1 and GSTT1 enzymes. The part of the variance that could be explained by differences in biotransformation genotypes seemed to be of the same order of magnitude as the variance explained by differences in exposure. In the control group as well as in the occupationally exposed group, the highest 1-OHP levels were observed in individuals carrying the CYP1A1 Ile/Val genotype who were also of the GSTM1 null genotype. The results show that urinary 1-OHP is a sensitive indicator of recent human exposure to PAHs and that it may also to some extent reflect the interindividual variation in susceptibility to PAHs.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Suwan-ampai, A. Navas-Acien, P. T. Strickland, and J. Agnew Involuntary Tobacco Smoke Exposure and Urinary Levels of Polycyclic Aromatic Hydrocarbons in the United States, 1999 to 2002 Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 884 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Pesch, M. Kappler, K. Straif, B. Marczynski, R. Preuss, B. Rossbach, H.-P. Rihs, T. Weiss, S. Rabstein, C. Pierl, et al. Dose-Response Modeling of Occupational Exposure to Polycyclic Aromatic Hydrocarbons with Biomarkers of Exposure and Effect Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1863 - 1873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Abnet, R. B. Fagundes, P. T. Strickland, F. Kamangar, M. J. Roth, P. R. Taylor, and S. M. Dawsey The influence of genetic polymorphisms in Ahr, CYP1A1, CYP1A2, CYP1B1, GST M1, GST T1 and UGT1A1 on urine 1-hydroxypyrene glucuronide concentrations in healthy subjects from Rio Grande do Sul, Brazil Carcinogenesis, January 1, 2007; 28(1): 112 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Masson, L. Sharp, S. C. Cotton, and J. Little Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Viau, C. Zaoui, and S. Charbonneau Dietary Fibers Reduce the Urinary Excretion of 1-Hydroxypyrene following Intravenous Administration of Pyrene Toxicol. Sci., March 1, 2004; 78(1): 15 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yang, J.-Y. Jang, S. Kim, S.-M. Lee, S.-S. Chang, H.-K. Cheong, E. Lee, D. Kang, H. Kim, T. Kawamoto, et al. Genetic effects on urinary 1-hydroxypyrene levels in a Korean population Carcinogenesis, June 1, 2003; 24(6): 1085 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer Carcinogenesis, June 1, 2002; 23(6): 907 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Zhang, M Ichiba, K Hara, S Zhang, T Hanaoka, G Pan, Y Yamano, K Takahashi, and K Tomokuni Urinary 1-hydroxypyrene in coke oven workers relative to exposure, alcohol consumption, and metabolic enzymes Occup. Environ. Med., November 1, 2001; 58(11): 716 - 721. [Abstract] [Full Text]
|
|
|
|
|
|
H.-M. Nan, H. Kim, H.-S. Lim, J. K. Choi, T. Kawamoto, J.-W. Kang, C.-H. Lee, Y.-D. Kim, and E. H. Kwon Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations Carcinogenesis, May 1, 2001; 22(5): 787 - 793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-C. Hong, H. Kim, M.-W. Im, K.-H. Lee, B.-H. Woo, and D. C. Christiani Maternal Genetic Effects on Neonatal Susceptibility to Oxidative Damage From Environmental Tobacco Smoke J Natl Cancer Inst, April 18, 2001; 93(8): 645 - 647. [Full Text] [PDF]
|
|